Literature DB >> 7904296

Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care.

M T Schechter1, R S Hogg, B Aylward, K J Craib, T N Le, J S Montaner.   

Abstract

In order to identify socioeconomic characteristics associated with slower progression of HIV infection, we conducted a nested case-control study within a cohort of 729 homosexual men. The study compared non-progressors (defined as subjects who, at a follow-up visit during the period October 1989-December 1990, had been HIV positive for at least 5 years, had a CD4 count > 0.5 x 10(9)/l, had a Karnofsky score of 100%, were at Centers for Disease Control (CDC) Stage III or less, and had never received zidovudine or prophylaxis against Pneumocystis carinii pneumonia) with rapid progressors (defined as those who had developed AIDS other than Kaposi's sarcoma within 6 years of seroconversion, or within 5 years of enrollment if already seropositive). Rapidly progressing subjects were matched to non-progressing subjects on the basis of date of enrollment if seroprevalent and date of seroconversion if seroincident. Socioeconomic data were taken from the questionnaire obtained at enrollment into the cohort during 1982-84. There were 41 subjects in each group. A significantly higher proportion of the non-progressors had annual incomes above $10,000, at enrollment (85 vs 62%; p = 0.019). Similarly, a greater proportion of the non-progressors were more likely to have finished secondary school (100 vs 84%; p = 0.020) than rapid progressors. A higher proportion of non-progressors reported employment in management and professional positions (35 vs 15%). The non-progressing group also had a significantly higher socioeconomic index based on self-reported occupation (45.1 vs 38.3; p = 0.035). The association with higher income persisted even after adjustment for baseline CD4 count and symptoms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904296     DOI: 10.1016/0895-4356(94)90034-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  Modern antiretroviral therapy improves life expectancy of gay and bisexual males in Vancouver's West End.

Authors:  E Wood; S Low-Beer; K Bartholomew; M Landolt; D Oram; M V O'Shaughnessy; R S Hogg
Journal:  Can J Public Health       Date:  2000 Mar-Apr

2.  Access and use of medications in HIV disease.

Authors:  S R Smith; D M Kirking
Journal:  Health Serv Res       Date:  1999-04       Impact factor: 3.402

3.  Widening social inequalities in mortality: the case of Barcelona, a southern European city.

Authors:  C Borrell; A Plasència; I Pasarin; V Ortún
Journal:  J Epidemiol Community Health       Date:  1997-12       Impact factor: 3.710

4.  The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa.

Authors:  Helen Byakwaga; Peter W Hunt; Miriam Laker-Oketta; David V Glidden; Yong Huang; Bosco M Bwana; A Rain Mocello; John Bennett; Victoria Walusansa; Sheila C Dollard; David R Bangsberg; Edward K Mbidde; Jeffrey N Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

5.  Poverty, hunger, education, and residential status impact survival in HIV.

Authors:  James McMahon; Christine Wanke; Norma Terrin; Sally Skinner; Tamsin Knox
Journal:  AIDS Behav       Date:  2011-10

6.  Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999.

Authors:  J del Amo; J del Romero; A Barrasa; S Pérez-Hoyos; C Rodríguez; M Díez; S García; V Soriano; J Castilla
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.